The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]

  • See Evidence submitted by expert panel for details.

Variant: NM_001110792.2(MECP2):c.491C>G (p.Pro164Arg)

CA270424

143579 (ClinVar)

Gene: MECP2
Condition: Rett syndrome
Inheritance Mode: X-linked inheritance
UUID: 6d7ad90d-38fc-4fab-9db8-b6da72e59655

HGVS expressions

NM_001110792.2:c.491C>G
NM_001110792.2(MECP2):c.491C>G (p.Pro164Arg)
NC_000023.11:g.154031373G>C
CM000685.2:g.154031373G>C
NC_000023.10:g.153296824G>C
CM000685.1:g.153296824G>C
NC_000023.9:g.152950018G>C
NG_007107.2:g.110755C>G
NG_007107.3:g.110731C>G
ENST00000303391.11:c.455C>G
ENST00000453960.7:c.491C>G
ENST00000637917.1:n.65+23C>G
ENST00000303391.10:c.455C>G
ENST00000369957.5:c.*509C>G
ENST00000407218.5:c.468+23C>G
ENST00000453960.6:c.491C>G
ENST00000486506.5:n.2803C>G
ENST00000611468.1:c.443C>G
ENST00000619732.4:c.455C>G
ENST00000622433.4:c.443C>G
ENST00000628176.2:c.432+23C>G
NM_001110792.1:c.491C>G
NM_001316337.1:c.176C>G
NM_004992.3:c.455C>G
NM_001316337.2:c.176C>G
NM_001369391.2:c.176C>G
NM_001369392.2:c.176C>G
NM_001369393.2:c.176C>G
NM_001369394.1:c.176C>G
NM_001369394.2:c.176C>G
NM_001386137.1:c.-129+23C>G
NM_001386138.1:c.-129+23C>G
NM_001386139.1:c.-129+23C>G
NM_004992.4:c.455C>G

Pathogenic

Met criteria codes 8
PS4 PS2_Very Strong PP3 PP4 PM5 PM1 PS3_Supporting PM2_Supporting

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specifications for this VCEP
Evidence submitted by expert panel
Rett and Angelman-like Disorders VCEP
The p.Pro152Arg variant in MECP2 (NM_004992.3) has been reported in at least 6 de novo occurrences (biological parentage unconfirmed) in patients with Rett syndrome (PMID 10767337, 10814718, 11241840) and in at least 4 other individuals with clinical features of Rett syndrome (PMID 11055898, 2385859, RettBASE) (PM6_very strong, PP4, PS4). The p.Pro152Arg variant occurs in the well-characterized methyl-DNA binding (MDB) functional domain of MECP2 (PM1). A pathogenic missense variant (p.Pro152Ala) has been previously identified within this codon which indicates that this residue is critical to the function of the protein (PMID 18989701, 18989701, 27929079, 26842955, ClinVar) (PM5). Computational prediction analysis tools suggests a deleterious impact; however, this information does not predict clinical significance on its own (PP3). Immunofluorescence assays have shown that the p.Pro152Arg variant in MECP2 impacts heterochromatin clustering (PMID 21831886, 22923521) (PS3_supporting). The p.Pro152Arg variant in MECP2 is absent from gnomAD (PM2_supporting). In summary, the p.Pro152Arg variant in MECP2 is classified as Pathogenic for Rett syndrome based on the ACMG/AMP criteria (PM6_very strong, PS4, PM1, PM5, PS3_supporting, PM2_supporting, PP3, PP4).
Met criteria codes
PS4
The p.Pro152Arg variant has been observed in at least 4 other individuals with clinical features of Rett syndrome (PMID 11055898, 2385859, 10814718, 11241840, RettBASE) (PS4).
PS2_Very Strong
The p.Pro152Arg variant in MECP2 has been reported in at least 6 de novo occurrences (biological parentage unconfirmed) in patients with Rett syndrome (PMID: 10767337, 10814718, 11241840) (PM6_very strong). Using PS2_very strong as a placeholder for PM6_very strong, which is not available in the drop-down menu.
PP3
Computational prediction analysis tools suggests a deleterious impact; however, this information does not predict clinical significance on its own (PP3).
PP4
The p.Pro152Arg variant in MECP2 has been reported in an individual with a clinical phenotype suggestive of Rett syndrome (PMID: 10767337).
PM5
A pathogenic missense variant (p.Pro152Ala) has been previously identified within this codon which indicates that this residue is critical to the function of the protein (PMID 18989701, 18989701, 27929079, 26842955, ClinVar) (PM5). Grantham score Pro > Ala = 27 Grantham score Pro > Arg = 103
PM1
The p.Pro152Arg variant occurs in the well-characterized methyl-DNA binding (MDB) functional domain of MECP2 (PM1).
PS3_Supporting
Immunofluorescence assays have shown that this variant impacts heterochromatin clustering (PMID 21831886, 22923521) (PS3_supporting).
PM2_Supporting
The p.Pro152Arg variant in MECP2 is absent from gnomAD (PM2_supporting).
Approved on: 2021-10-26
Published on: 2021-12-27
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.